Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy
Clinical trial NCT00420303 · COMPLETED
Trial details
- NCT number
- NCT00420303
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2008-09-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.